List of insiders holdings for Tourmaline Bio Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Ildstad Suzanne Director | 2023-06-14 18:58:15 | 3,791,892 1,308,410 | 5,100,302 | Form 4 |
| Requadt Scott Former Chief Executive Officer | 2023-07-06 17:19:16 | 578,403 449,766 | 1,028,169 | Form 4 |
| Castelein Caley Director | 2023-10-27 17:43:29 | 516,519 458,039 | 974,558 | Form 4 |
| MCDADE MARK Director | 2024-01-31 16:26:17 | 518 741,691 | 742,209 | Form 4 |
| Kulkarni Sandeep Chidambar CEO | 2023-11-20 18:15:47 | 729,735 0 | 729,735 | Form 4 |
| Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 2023-10-30 17:16:49 | 322,077 0 | 322,077 | Form 13D |
| Zdanowski Michael Chief Technology Officer | 2023-02-03 17:02:36 | 300,000 0 | 300,000 | Form 4 |
| CHYUNG YUNG H. Chief Medical Officer | 2023-10-23 20:20:18 | 274,262 0 | 274,262 | Form 4 |
| MIDDLEKAUFF W BRADFORD CBO, GC and Secretary | 2023-10-23 20:29:01 | 240,966 0 | 240,966 | Form 4 |
| Krieger Nancy Chief Medical Officer | 2023-02-03 16:59:50 | 240,000 0 | 240,000 | Form 4 |
| Johnson Kevin Bruce Chief Regulatory Officer | 2023-10-23 20:21:31 | 200,754 0 | 200,754 | Form 4 |
| Clarus Defined Exit I L.P. Clarus DE II L.P. Clarus IV-A L.P. Clarus IV-B L.P. Clarus IV-C L.P. Clarus IV-D L.P. Clarus Ventures DE GP L.P. Clarus IV GP L.P. Blackstone Clarus DE L.L.C. Blackstone Clarus GP L.L.C. 10% Owner | 2021-05-13 21:59:55 | 0 160,044 | 160,044 | Form 4 |
| Jones Susan Dana Chief Technology Officer | 2023-10-23 20:23:01 | 145,927 0 | 145,927 | Form 4 |
| Thiara Parvinder Director | 2023-11-20 18:14:25 | 83,782 0 | 83,782 | Form 4 |
| Fenton Mary Kay Chief Financial Officer | 2023-07-06 17:20:59 | 68,054 0 | 68,054 | Form 4 |
| Robinson Ryan F. Interim CFO | 2023-10-23 20:30:39 | 56,211 0 | 56,211 | Form 4 |
| KANTOFF AARON Director | 2023-10-26 17:00:17 | 45,391 0 | 45,391 | Form 4 |
| Nader Francois Director | 2023-06-14 19:00:36 | 41,000 0 | 41,000 | Form 4 |
| Srivastava Sapna Director | 2023-10-23 20:31:53 | 20,518 0 | 20,518 | Form 4 |
| Smith Karen L. Director | 2023-06-14 19:02:37 | 20,500 0 | 20,500 | Form 4 |
| Shah Gaurav Director | 2023-06-14 19:01:25 | 20,500 0 | 20,500 | Form 4 |
| Agarwala Sandip Director | 2023-06-14 18:56:33 | 20,500 0 | 20,500 | Form 4 |
| MACKAY GEOFFREY Director | 2023-06-14 18:59:05 | 20,500 0 | 20,500 | Form 4 |
| SIEGALL CLAY B Director | 2023-12-15 16:23:26 | 20,000 0 | 20,000 | Form 4 |
| Chester Cariad Director | 2023-10-23 18:27:53 | 0 0 | 0 | Form 3 |
| Clarus Lifesciences III L.P. Clarus Ventures III GP L.P. Blackstone Clarus III L.L.C. Blackstone Clarus GP L.P. Blackstone Holdings I L.P. Blackstone Holdings II L.P. Blackstone Holdings I/II GP L.L.C. Blackstone Group Inc Blackstone Group Management L.L.C. SCHWARZMAN STEPHEN A 10% Owner | 2024-02-09 17:24:53 | 0 0 | 0 | Form 13G |
| GALAKATOS NICHOLAS Director | 2021-05-06 21:25:52 | 0 0 | 0 | Form 3 |